Eastgate; Martin D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Eastgate; Martin D..The latest application filed is for "process for the preparation of n-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1- ,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide".

Company Profile

4.12.22

Eastgate; Martin D. - Titusville NJ
Eastgate; Martin D. - New Brunswick NJ
Eastgate; Martin D. - Trenton NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process For The Preparation Of N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1- ,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide App 20220177482 - Aytar; Burcu Selin ; et al.	2022-06-09
Process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1- ,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamide Grant 11,254,679 - Aytar , et al. February 22, 2	2022-02-22
Synthetic Processes For The Production Of 1-((3s,4r)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl)-3-pheny- Lurea App 20210395200 - Ortiz; Adrian ; et al.	2021-12-23
Non-chromatographic Purification Of Macrocyclic Peptides By A Resin Catch And Release App 20210079046 - CREECH; Gardner S. ; et al.	2021-03-18
Process For The Preparation Of N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1- ,3,5]triazin-4-ylamino App 20200223852 - Aytar; Burcu Selin ; et al.	2020-07-16
Novel Phosphorous (v)-based Reagents, Processes For The Preparation Thereof, And Their Use In Making Stereo-defined Organophosho App 20190322694 - SCHMIDT; Michael Anthony ; et al.	2019-10-24
Methods of producing an HIV maturation inhibitor Grant 10,221,208 - Ortiz , et al.	2019-03-05
Process and intermediates for making tubulysin analogs Grant 10,106,560 - Ortiz , et al. October 23, 2	2018-10-23
Methods Of Producing An Hiv Maturation Inhibitor App 20180072691 - ORTIZ; Adrian ; et al.	2018-03-15
Process And Intermediates For Making Tubulysin Analogs App 20170362259 - ORTIZ; Adrian ; et al.	2017-12-21
Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-- 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide Grant 9,518,058 - Eastgate , et al. December 13, 2	2016-12-13
PROCESS FOR THE PREPARATION OF N,N-DICYCLOPROPYL-4-(1,5-DIMETHYL-1H-PYRAZOL-3-YLAMINO)-6-ETHYL-1-METHYL-- 1,6-DIHYDROIMIDAZO[4,5-d]PYRROLO[2,3-b]PYRIDINE-7-CARBOXAMIDE App 20160229854 - Eastgate; Martin D. ; et al.	2016-08-11
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,403,821 - Eastgate , et al. August 2, 2	2016-08-02
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,394,322 - Eastgate , et al. July 19, 2	2016-07-19
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,376,458 - Eastgate , et al. June 28, 2	2016-06-28
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20160152644 - Eastgate; Martin D. ; et al.	2016-06-02
Tert-butyl Sulphoxide Method For Producing Festinavir App 20160130260 - Ortiz; Adrian ; et al.	2016-05-12
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20160108029 - Eastgate; Martin D. ; et al.	2016-04-21
Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication Grant 9,273,067 - Naidu , et al. March 1, 2	2016-03-01
Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,255,113 - Eastgate , et al. February 9, 2	2016-02-09
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,249,168 - Eastgate , et al. February 2, 2	2016-02-02
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 9,243,010 - Eastgate , et al. January 26, 2	2016-01-26
Pyrazolopyrimidine Macrocycles as Inhibitors of Human Immunodeficiency Virus Replication App 20150232481 - Naidu; B. Narasimhulu ; et al.	2015-08-20
Process For Preparing Diastereomerically Enriched Phosphoramidate Derivatives Of Nucleoside Compounds For Treatment Of Viral Infections App 20150183818 - Tran; Kristy ; et al.	2015-07-02
Process For The Preparation Of 2-c-methyl-d-ribonic-gamma-lactone App 20150126752 - Steinhardt; Sarah Evelyn ; et al.	2015-05-07
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038717 - Eastgate; Martin D. ; et al.	2015-02-05
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038709 - Eastgate; Martin D. ; et al.	2015-02-05
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038710 - Eastgate; Martin D. ; et al.	2015-02-05
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038712 - Eastgate; Martin D. ; et al.	2015-02-05
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038716 - Eastgate; Martin D. ; et al.	2015-02-05
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20150038711 - Eastgate; Martin D. ; et al.	2015-02-05
Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound Grant 8,889,869 - Eastgate , et al. November 18, 2	2014-11-18
Methods For The Preparation Of Hiv Attachment Inhibitor Piperazine Prodrug Compound App 20130203992 - Eastgate; Martin D. ; et al.	2013-08-08
Modulators Of Chemokine Receptor Activity Crystalline Forms And Process App 20080027083 - Yang; Michael G. ; et al.	2008-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.